Svas Biosana S.p.A. (BIT:SVS)
Italy · Delayed Price · Currency is EUR 8.00
0.00 (0.00%)
At close: Oct 16, 2026
Svas Biosana Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 138.1 | 139.11 | 120.31 | 118.28 | 97.23 | 81.09 |
Other Revenue | 3.65 | 2.43 | 1.97 | 3.35 | 2.29 | 0.91 |
| 141.74 | 141.54 | 122.29 | 121.63 | 99.51 | 81.99 | |
Revenue Growth | 5.03% | 15.75% | 0.54% | 22.23% | 21.37% | 6.11% |
Cost of Revenue | 100.25 | 101.47 | 87.92 | 89.37 | 70.78 | 58.53 |
Gross Profit | 41.49 | 40.07 | 34.37 | 32.26 | 28.73 | 23.47 |
Selling, General & Admin | 19.5 | 18.59 | 16.43 | 15.64 | 16.84 | 11.02 |
Amortization of Goodwill & Intangibles | 2.58 | 2.55 | 1.9 | 1.79 | 1.81 | 1.76 |
Other Operating Expenses | 3.53 | 3.16 | 2.63 | 2.37 | -0 | 1.8 |
Operating Expenses | 29.19 | 27.83 | 24.56 | 23.69 | 22.45 | 17.69 |
Operating Income | 12.3 | 12.24 | 9.8 | 8.57 | 6.28 | 5.77 |
Interest Expense | -3.98 | -4.13 | -4.36 | -3.79 | -1.86 | -1.87 |
Interest & Investment Income | 0.08 | 0.08 | 0.11 | 0.11 | 0.06 | 0 |
Currency Exchange Gain (Loss) | -0.06 | 0.07 | -0.04 | 0.03 | -0.13 | -0.12 |
Other Non Operating Income (Expenses) | 0.39 | 0.42 | 0.64 | 0.6 | 0.34 | 0.23 |
EBT Excluding Unusual Items | 8.73 | 8.69 | 6.16 | 5.51 | 4.68 | 4.02 |
Gain (Loss) on Sale of Investments | 0.45 | 0.45 | 1.85 | 1.29 | - | - |
Asset Writedown | - | - | - | - | -0.03 | - |
Pretax Income | 9.18 | 9.14 | 8.01 | 6.8 | 4.66 | 4.02 |
Income Tax Expense | 2.47 | 2.37 | 2.13 | 1.67 | 1.09 | 0.86 |
Earnings From Continuing Operations | 6.71 | 6.77 | 5.88 | 5.13 | 3.57 | 3.16 |
Net Income to Company | - | 6.77 | 5.88 | 5.13 | 3.57 | 3.16 |
Minority Interest in Earnings | 0.04 | 0 | -0 | -0 | -0 | -0 |
Net Income | 6.75 | 6.77 | 5.87 | 5.12 | 3.57 | 3.16 |
Net Income to Common | 6.75 | 6.77 | 5.87 | 5.12 | 3.57 | 3.16 |
Net Income Growth | 0.13% | 15.24% | 14.68% | 43.52% | 12.97% | 25.70% |
Shares Outstanding (Basic) | - | 5 | 5 | - | 5 | - |
Shares Outstanding (Diluted) | - | 5 | 5 | - | 5 | - |
Shares Change | - | -1.74% | - | - | - | - |
EPS (Basic) | - | 1.29 | 1.10 | - | 0.66 | - |
EPS (Diluted) | - | 1.29 | 1.10 | - | 0.66 | - |
EPS Growth | - | 17.28% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 10.56 | 2.73 | 1.42 | 0.52 | 1.9 | -0.08 |
Free Cash Flow Per Share | - | 0.52 | 0.27 | - | 0.35 | - |
Dividend Per Share | 0.200 | 0.200 | 0.250 | 0.300 | - | - |
Dividend Growth | -20.00% | -20.00% | -16.67% | - | - | - |
Gross Margin | 29.27% | 28.31% | 28.10% | 26.52% | 28.87% | 28.62% |
Operating Margin | 8.68% | 8.65% | 8.02% | 7.04% | 6.31% | 7.04% |
Profit Margin | 4.76% | 4.78% | 4.80% | 4.21% | 3.59% | 3.85% |
Free Cash Flow Margin | 7.45% | 1.93% | 1.17% | 0.43% | 1.91% | -0.10% |
EBITDA | 17.7 | 17.58 | 15.05 | 13.59 | 11.07 | 10.3 |
EBITDA Margin | 12.49% | 12.42% | 12.31% | 11.17% | 11.13% | 12.57% |
D&A For EBITDA | 5.4 | 5.34 | 5.25 | 5.02 | 4.79 | 4.53 |
EBIT | 12.3 | 12.24 | 9.8 | 8.57 | 6.28 | 5.77 |
EBIT Margin | 8.68% | 8.65% | 8.02% | 7.04% | 6.31% | 7.04% |
Effective Tax Rate | 26.90% | 25.93% | 26.63% | 24.60% | 23.31% | 21.33% |
Revenue as Reported | 143.34 | 142.67 | 122.77 | 122.34 | 102.28 | 81.52 |